title: Cost-effectiveness of antepartum prevention of Rh immunization.
abstract: While antepartum prophylaxis of Rh immunization is much more costly and the postpartum program is much more cost-effective, the question is whether the antepartum program is sufficiently cost-effective to warrant its use. How, in any given region, should the issue be tackled? This article addresses that question.
mesh_terms: D000917:Antibody Formation; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D011247:Pregnancy; D011295:Prenatal Care / Q000191:economics*; D012204:Rh-Hr Blood-Group System / Q000276:immunology*
chemical_list: D012204:Rh-Hr Blood-Group System